Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Jay Amsterdam

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Devices

Placebos

Phenomena

Recurrence

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
16
Reimherr, Frederick
16
Maislin, Greg
15
Quitkin, Frederic
13
Shults, Justine
10
Brunswick, David
10
Fawcett, Jan
10
Hornig-Rohan, Mady
10
Winokur, Andrew
9
Beasley, Charles
8
Hollon, Steven
8
Michelson, David
8
DeRubeis, Robert
7
Gallop, Robert
7
Shelton, Richard
7
Rosenbaum, Jerrold

Sign-in to see all Coauthors

Publications

TOP 3
Richmond T S; Amsterdam J D; Guo W; Ackerson T; Gracias V; Robinson K M; Hollander J E
The effect of post-injury depression on return to pre-injury function: a prospective cohort study.
Fournier Jay C; DeRubeis Robert J; Shelton Richard C; Hollon Steven D; Amsterdam Jay D; Gallop Robert
Prediction of response to medication and cognitive therapy in the treatment of moderate to severe depression.
Amsterdam Jay D; Li Yimei; Soeller Irene; Rockwell Kenneth; Mao Jun James; Shults Justine
A randomized, double-blind, placebo-controlled trial of oral Matricaria recutita (chamomile) extract therapy for generalized anxiety disorder.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Jay Amsterdam (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Richmond T S; Amsterdam J D; Guo W; Ackerson T; Gracias V; Robinson K M; Hollander J E
The effect of post-injury depression on return to pre-injury function: a prospective cohort study.
Psychological medicine 2009;39(10):1709-20.
2009: Fournier Jay C; DeRubeis Robert J; Shelton Richard C; Hollon Steven D; Amsterdam Jay D; Gallop Robert
Prediction of response to medication and cognitive therapy in the treatment of moderate to severe depression.
Journal of consulting and clinical psychology 2009;77(4):775-87.
2009: Amsterdam Jay D; Li Yimei; Soeller Irene; Rockwell Kenneth; Mao Jun James; Shults Justine
A randomized, double-blind, placebo-controlled trial of oral Matricaria recutita (chamomile) extract therapy for generalized anxiety disorder.
Journal of clinical psychopharmacology 2009;29(4):378-82.
2009: Amsterdam Jay D; Shults Justine
Does tachyphylaxis occur after repeated antidepressant exposure in patients with Bipolar II major depressive episode?
Journal of affective disorders 2009;115(1-2):234-40.
2009: Lundgren J D; Amsterdam J; Newberg A; Allison K C; Wintering N; Stunkard A J
Differences in serotonin transporter binding affinity in patients with major depressive disorder and night eating syndrome.
Eating and weight disorders : EWD 2009;14(1):45-50.
2009: Amsterdam Jay D; Wang Chia-Hao; Shwarz Michelle; Shults Justine
Venlafaxine versus lithium monotherapy of rapid and non-rapid cycling patients with bipolar II major depressive episode: a randomized, parallel group, open-label trial.
Journal of affective disorders 2009;112(1-3):219-30.
2009: Amsterdam Jay D; Williams David; Michelson David; Adler Lenard A; Dunner David L; Nierenberg Andrew A; Reimherr Frederick W; Schatzberg Alan F
Tachyphylaxis after repeated antidepressant drug exposure in patients with recurrent major depressive disorder.
Neuropsychobiology 2009;59(4):227-33.
2008: Tohen Mauricio; Vieta Eduard; Goodwin Guy M; Sun Bin; Amsterdam Jay D; Banov Michael; Shekhar Anantha; Aaronson Scott T; Bardenstein Leonid; Grecu-Gabos Iosif; Tochilov Vladimir; Prelipceanu Dan; Oliff Heather S; Kryzhanovskaya Ludmila; Bowden Charles
Olanzapine versus divalproex versus placebo in the treatment of mild to moderate mania: a randomized, 12-week, double-blind study.
The Journal of clinical psychiatry 2008;69(11):1776-89.
2008: Bhar Sunil S; Gelfand Lois A; Schmid Sabine P; Gallop Robert; DeRubeis Robert J; Hollon Steven D; Amsterdam Jay D; Shelton Richard C; Beck Aaron T
Sequence of improvement in depressive symptoms across cognitive therapy and pharmacotherapy.
Journal of affective disorders 2008;110(1-2):161-6.
2008: Amsterdam Jay D; Shults Justine
Comparison of short-term venlafaxine versus lithium monotherapy for bipolar II major depressive episode: a randomized open-label study.
Journal of clinical psychopharmacology 2008;28(2):171-81.
2008: Fournier Jay C; DeRubeis Robert J; Shelton Richard C; Gallop Robert; Amsterdam Jay D; Hollon Steven D
Antidepressant medications v. cognitive therapy in people with depression with or without personality disorder.
The British journal of psychiatry : the journal of mental science 2008;192(2):124-9.
2008: Amsterdam Jay D; Shults Justine; Rutherford Nancy
Open-label study of s-citalopram therapy of chronic fatigue syndrome and co-morbid major depressive disorder.
Progress in neuro-psychopharmacology & biological psychiatry 2008;32(1):100-6.
2007: Leykin Yan; Derubeis Robert J; Gallop Robert; Amsterdam Jay D; Shelton Richard C; Hollon Steven D
The relation of patients' treatment preferences to outcome in a randomized clinical trial.
Behavior therapy 2007;38(3):209-17.
2007: Richmond Therese S; Hollander Judd E; Ackerson Theimann H; Robinson Keith; Gracias Vicente; Shults Justine; Amsterdam Jay
Psychiatric disorders in patients presenting to the Emergency Department for minor injury.
Nursing research 2007;56(4):275-82.
2007: Tang Tony Z; Derubeis Robert J; Hollon Steven D; Amsterdam Jay; Shelton Richard
Sudden gains in cognitive therapy of depression and depression relapse/recurrence.
Journal of consulting and clinical psychology 2007;75(3):404-8.
2007: Michelson David; Adler Lenard A; Amsterdam Jay D; Dunner David L; Nierenberg Andrew A; Reimherr Frederick W; Schatzberg Alan F; Kelsey Douglas K; Williams David W
Addition of atomoxetine for depression incompletely responsive to sertraline: a randomized, double-blind, placebo-controlled study.
The Journal of clinical psychiatry 2007;68(4):582-7.
2007: Leykin Yan; Amsterdam Jay D; DeRubeis Robert J; Gallop Robert; Shelton Richard C; Hollon Steven D
Progressive resistance to a selective serotonin reuptake inhibitor but not to cognitive therapy in the treatment of major depression.
Journal of consulting and clinical psychology 2007;75(2):267-76.
2007: Cusin Cristina; Fava Maurizio; Amsterdam Jay D; Quitkin Frederic M; Reimherr Frederick W; Beasley Charles M; Rosenbaum Jerrold F; Perlis Roy H
Early symptomatic worsening during treatment with fluoxetine in major depressive disorder: prevalence and implications.
The Journal of clinical psychiatry 2007;68(1):52-7.
2007: Newberg Andrew; Amsterdam Jay; Shults Justine
Dopamine transporter density may be associated with the depressed affect in healthy subjects.
Nuclear medicine communications 2007;28(1):3-6.
2007: Amsterdam Jay D; Newberg Andrew B
A preliminary study of dopamine transporter binding in bipolar and unipolar depressed patients and healthy controls.
Neuropsychobiology 2007;55(3-4):167-70.
2007: Perlis Roy H; Beasley Charles M; Wines James D; Tamura Roy N; Cusin Cristina; Shear Deborah; Amsterdam Jay; Quitkin Frederick; Strong Robert E; Rosenbaum Jerrold F; Fava Maurizio
Treatment-associated suicidal ideation and adverse effects in an open, multicenter trial of fluoxetine for major depressive episodes.
Psychotherapy and psychosomatics 2007;76(1):40-6.
2006: Amsterdam Jay D; Bodkin J Alexander
Selegiline transdermal system in the prevention of relapse of major depressive disorder: a 52-week, double-blind, placebo-substitution, parallel-group clinical trial.
Journal of clinical psychopharmacology 2006;26(6):579-86.
2006: Amsterdam Jay D; Shults Justine; Rutherford Nancy; Schwartz Stanley
Safety and efficacy of s-citalopram in patients with co-morbid major depression and diabetes mellitus.
Neuropsychobiology 2006;54(4):208-14.
2005: Amsterdam Jay D; Shults Justine
MAOI efficacy and safety in advanced stage treatment-resistant depression--a retrospective study.
Journal of affective disorders 2005;89(1-3):183-8.
2005: Amsterdam Jay D; Shults Justine
Fluoxetine monotherapy of bipolar type II and bipolar NOS major depression: a double-blind, placebo-substitution, continuation study.
International clinical psychopharmacology 2005;20(5):257-64.
2005: Szuba Martin P; Amsterdam Jay D; Fernando Antonio T; Gary Keith A; Whybrow Peter C; Winokur Andrew
Rapid antidepressant response after nocturnal TRH administration in patients with bipolar type I and bipolar type II major depression.
Journal of clinical psychopharmacology 2005;25(4):325-30.
2005: Amsterdam Jay D; Shults Justine
Comparison of fluoxetine, olanzapine, and combined fluoxetine plus olanzapine initial therapy of bipolar type I and type II major depression--lack of manic induction.
Journal of affective disorders 2005;87(1):121-30.
2005: Newberg Andrew B; Amsterdam Jay D; Wintering Nancy; Ploessl Karl; Swanson Randel L; Shults Justine; Alavi Abass
123I-ADAM binding to serotonin transporters in patients with major depression and healthy controls: a preliminary study.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2005;46(6):973-7.
2005: Hollon Steven D; DeRubeis Robert J; Shelton Richard C; Amsterdam Jay D; Salomon Ronald M; O'Reardon John P; Lovett Margaret L; Young Paula R; Haman Kirsten L; Freeman Brent B; Gallop Robert
Prevention of relapse following cognitive therapy vs medications in moderate to severe depression.
Archives of general psychiatry 2005;62(4):417-22.
2005: DeRubeis Robert J; Hollon Steven D; Amsterdam Jay D; Shelton Richard C; Young Paula R; Salomon Ronald M; O'Reardon John P; Lovett Margaret L; Gladis Madeline M; Brown Laurel L; Gallop Robert
Cognitive therapy vs medications in the treatment of moderate to severe depression.
Archives of general psychiatry 2005;62(4):409-16.
2004: Reivich Martin; Amsterdam Jay D; Brunswick David J; Shiue Chyng Yann
PET brain imaging with [11C](+)McN5652 shows increased serotonin transporter availability in major depression.
Journal of affective disorders 2004;82(2):321-7.
2004: Staab Jeffrey P; Ruckenstein Michael J; Amsterdam Jay D
A prospective trial of sertraline for chronic subjective dizziness.
The Laryngoscope 2004;114(9):1637-41.
2004: Boyd Rhonda C; Amsterdam Jay D
Mood disorders in women from adolescence to late life: an overview.
Clinical obstetrics and gynecology 2004;47(3):515-26.
2004: Brunswick David J; Goodman David B P; O'Reardon John P; Chopra Mohit; Amsterdam Jay D
Pindolol does not augment cortisol and prolactin responses to paroxetine in healthy subjects.
Progress in neuro-psychopharmacology & biological psychiatry 2004;28(3):477-80.
2004: Amsterdam Jay D; Brunswick David J; Gibertini Michael
Sustained efficacy of gepirone-IR in major depressive disorder: a double-blind placebo substitution trial.
Journal of psychiatric research 2004;38(3):259-65.
2004: Amsterdam Jay D; Shults Justine; Brunswick David J; Hundert Miriam
Short-term fluoxetine monotherapy for bipolar type II or bipolar NOS major depression - low manic switch rate.
Bipolar disorders 2004;6(1):75-81.
2003: Amsterdam Jay D; Brunswick David J
Antidepressant monotherapy for bipolar type II major depression.
Bipolar disorders 2003;5(6):388-95.
2003: Brunswick David J; Amsterdam Jay D; Mozley P David; Newberg Andrew
Greater availability of brain dopamine transporters in major depression shown by [99m Tc]TRODAT-1 SPECT imaging.
The American journal of psychiatry 2003;160(10):1836-41.
2003: Quitkin Frederic M; Petkova Eva; McGrath Patrick J; Taylor Bonnie; Beasley Charles; Stewart Jonathan; Amsterdam Jay; Fava Maurizio; Rosenbaum Jerrold; Reimherr Frederick; Fawcett Jan; Chen Ying; Klein Donald
When should a trial of fluoxetine for major depression be declared failed?
The American journal of psychiatry 2003;160(4):734-40.
2003: Amsterdam Jay D
A double-blind, placebo-controlled trial of the safety and efficacy of selegiline transdermal system without dietary restrictions in patients with major depressive disorder.
The Journal of clinical psychiatry 2003;64(2):208-14.
2002: Amsterdam Jay D; Brunswick David J; Hundert Miriam
A single-site, double-blind, placebo-controlled, dose-ranging study of YKP10A--a putative, new antidepressant.
Progress in neuro-psychopharmacology & biological psychiatry 2002;26(7-8):1333-8.
2002: Bodkin J Alexander; Amsterdam Jay D
Transdermal selegiline in major depression: a double-blind, placebo-controlled, parallel-group study in outpatients.
The American journal of psychiatry 2002;159(11):1869-75.
2002: Amsterdam Jay D; Brunswick David J
Site variability in treatment outcome in antidepressant trials.
Progress in neuro-psychopharmacology & biological psychiatry 2002;26(5):989-93.
2002: Brunswick David J; Amsterdam Jay D; Fawcett Jan; Quitkin Frederic M; Reimherr Frederick W; Rosenbaum Jerrold F; Beasley Charles M
Fluoxetine and norfluoxetine plasma concentrations during relapse-prevention treatment.
Journal of affective disorders 2002;68(2-3):243-9.
2002: Hornig-Rohan Mady; Amsterdam Jay D
Venlafaxine versus stimulant therapy in patients with dual diagnosis ADD and depression.
Progress in neuro-psychopharmacology & biological psychiatry 2002;26(3):585-9.
2001: Brunswick D J; Amsterdam J D; Fawcett J; Quitkin F M; Reimherr F W; Rosenbaum J F; Beasley C M
Fluoxetine and norfluoxetine plasma levels after discontinuing fluoxetine therapy.
Journal of clinical psychopharmacology 2001;21(6):616-8.
2001: Szuba M P; O'Reardon J P; Rai A S; Snyder-Kastenberg J; Amsterdam J D; Gettes D R; Wassermann E; Evans D L
Acute mood and thyroid stimulating hormone effects of transcranial magnetic stimulation in major depression.
Biological psychiatry 2001;50(1):22-7.
2000: Amsterdam J D; Garcia-España F
Venlafaxine monotherapy in women with bipolar II and unipolar major depression.
Journal of affective disorders 2000;59(3):225-9.
2000: McGrath P J; Stewart J W; Petkova E; Quitkin F M; Amsterdam J D; Fawcett J; Reimherr F W; Rosenbaum J F; Beasley C M
Predictors of relapse during fluoxetine continuation or maintenance treatment of major depression.
The Journal of clinical psychiatry 2000;61(7):518-24.
2000: Michelson D; Fava M; Amsterdam J; Apter J; Londborg P; Tamura R; Tepner R G
Interruption of selective serotonin reuptake inhibitor treatment. Double-blind, placebo-controlled trial.
The British journal of psychiatry : the journal of mental science 2000;176():363-8.
2000: Michelson D; Amsterdam J; Apter J; Fava M; Londborg P; Tamura R; Pagh L
Hormonal markers of stress response following interruption of selective serotonin reuptake inhibitor treatment.
Psychoneuroendocrinology 2000;25(2):169-77.
1999: Hornig M; Amsterdam J D; Kamoun M; Goodman D B
Autoantibody disturbances in affective disorders: a function of age and gender?
Journal of affective disorders 1999;55(1):29-37.
1999: Amsterdam J; Garcia-España F; Fawcett J; Quitkin F; Reimherr F; Rosenbaum J; Beasley C
Fluoxetine efficacy in menopausal women with and without estrogen replacement.
Journal of affective disorders 1999;55(1):11-7.
1999: Michelson D; Amsterdam J D; Quitkin F M; Reimherr F W; Rosenbaum J F; Zajecka J; Sundell K L; Kim Y; Beasley C M
Changes in weight during a 1-year trial of fluoxetine.
The American journal of psychiatry 1999;156(8):1170-6.
1999: Zajecka J; Amsterdam J D; Quitkin F M; Reimherr F W; Rosenbaum J F; Tamura R N; Sundell K L; Michelson D; Beasley C M
Changes in adverse events reported by patients during 6 months of fluoxetine therapy.
The Journal of clinical psychiatry 1999;60(6):389-94.
1999: Amsterdam J D; Garcia-Espana F; Fawcett J; Quitkin F M; Reimherr F W; Rosenbaum J F; Beasley C
Blood pressure changes during short-term fluoxetine treatment.
Journal of clinical psychopharmacology 1999;19(1):9-14.
1998: Fava M; Amsterdam J D; Deltito J A; Salzman C; Schwaller M; Dunner D L
A double-blind study of paroxetine, fluoxetine, and placebo in outpatients with major depression.
Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 1998;10(4):145-50.
1998: Amsterdam J D; Garcia-España F; Fawcett J; Quitkin F M; Reimherr F W; Rosenbaum J F; Schweizer E; Beasley C
Efficacy and safety of fluoxetine in treating bipolar II major depressive episode.
Journal of clinical psychopharmacology 1998;18(6):435-40.
1998: Amsterdam J
Efficacy and safety of venlafaxine in the treatment of bipolar II major depressive episode.
Journal of clinical psychopharmacology 1998;18(5):414-7.
1998: Reimherr F W; Amsterdam J D; Quitkin F M; Rosenbaum J F; Fava M; Zajecka J; Beasley C M; Michelson D; Roback P; Sundell K
Optimal length of continuation therapy in depression: a prospective assessment during long-term fluoxetine treatment.
The American journal of psychiatry 1998;155(9):1247-53.
1998: Zajecka J; Fawcett J; Amsterdam J; Quitkin F; Reimherr F; Rosenbaum J; Michelson D; Beasley C
Safety of abrupt discontinuation of fluoxetine: a randomized, placebo-controlled study.
Journal of clinical psychopharmacology 1998;18(3):193-7.
1998: Amsterdam J D; Hooper M B; Amchin J
Once- versus twice-daily venlafaxine therapy in major depression: a randomized, double-blind study.
The Journal of clinical psychiatry 1998;59(5):236-40.
1998: Hornig M; Goodman D B; Kamoun M; Amsterdam J D
Positive and negative acute phase proteins in affective subtypes.
Journal of affective disorders 1998;49(1):9-18.
1998: Stewart J W; Quitkin F M; McGrath P J; Amsterdam J; Fava M; Fawcett J; Reimherr F; Rosenbaum J; Beasley C; Roback P
Use of pattern analysis to predict differential relapse of remitted patients with major depression during 1 year of treatment with fluoxetine or placebo.
Archives of general psychiatry 1998;55(4):334-43.
1998: Amsterdam J D; Hooper M B
Bone density measurement in major depression.
Progress in neuro-psychopharmacology & biological psychiatry 1998;22(2):267-77.
1998: Amsterdam J D; García-España F; Rybakowski J
Rates of flu-like infection in patients with affective illness.
Journal of affective disorders 1998;47(1-3):177-82.
1997: Amsterdam J D; Garcia-España F; Goodman D; Hooper M; Hornig-Rohan M
Breast enlargement during chronic antidepressant therapy.
Journal of affective disorders 1997;46(2):151-6.
1997: Hornig M; Mozley P D; Amsterdam J D
HMPAO SPECT brain imaging in treatment-resistant depression.
Progress in neuro-psychopharmacology & biological psychiatry 1997;21(7):1097-114.
1997: Szuba M P; Hornig-Rohan M; Amsterdam J D
Rapid conversion from one monoamine oxidase inhibitor to another.
The Journal of clinical psychiatry 1997;58(7):307-10.
1997: Amsterdam J D; Fawcett J; Quitkin F M; Reimherr F W; Rosenbaum J F; Michelson D; Hornig-Rohan M; Beasley C M
Fluoxetine and norfluoxetine plasma concentrations in major depression: a multicenter study.
The American journal of psychiatry 1997;154(7):963-9.
1997: Amsterdam J D; García-España F; Rosenzweig M
Clomipramine augmentation in treatment-resistant depression.
Depression and anxiety 1997;5(2):84-90.
1996: Amsterdam J D; Maislin G; Hooper M B
Suppression of herpes simplex virus infections with oral lithium carbonate--a possible antiviral activity.
Pharmacotherapy 1996;16(6):1070-5.
1996: Sramek J J; Tansman M; Suri A; Hornig-Rohan M; Amsterdam J D; Stahl S M; Weisler R H; Cutler N R
Efficacy of buspirone in generalized anxiety disorder with coexisting mild depressive symptoms.
The Journal of clinical psychiatry 1996;57(7):287-91.
1996: Hornig-Rohan M; Wolkowitz O M; Amsterdam J D
Novel strategies for treatment-resistant depression.
The Psychiatric clinics of North America 1996;19(2):387-405.
1996: Amsterdam J D; Hornig-Rohan M
Treatment algorithms in treatment-resistant depression.
The Psychiatric clinics of North America 1996;19(2):371-86.
1996: Amsterdam J D; Fava M; Maislin G; Rosenbaum J; Hornig-Rohan M
TRH stimulation test as a predictor of acute and long-term antidepressant response in major depression.
Journal of affective disorders 1996;38(2-3):165-72.
1996: Mozley P D; Hornig-Rohan M; Woda A M; Kim H J; Alavi A; Payer F; Amsterdam J D
Cerebral HMPAO SPECT in patients with major depression and healthy volunteers.
Progress in neuro-psychopharmacology & biological psychiatry 1996;20(3):443-58.
1995: Amsterdam J D; Maislin G; Rosenzweig M; Halbrecht U
Gonadotropin (LH and FSH) response after submaximal GnRH stimulation in depressed premenopausal women and healthy controls.
Psychoneuroendocrinology 1995;20(3):311-21.
1994: Amsterdam J D; Hornig-Rohan M; Maislin G
Efficacy of alprazolam in reducing fluoxetine-induced jitteriness in patients with major depression.
The Journal of clinical psychiatry 1994;55(9):394-400.
1994: Amsterdam J D; Maislin G; Potter L
Fluoxetine efficacy in treatment resistant depression.
Progress in neuro-psychopharmacology & biological psychiatry 1994;18(2):243-61.
1993: Amsterdam J D; Hernz W J
Serum antibodies to herpes simplex virus types I and II in depressed patients.
Biological psychiatry 1993;34(6):417-20.
1992: Amsterdam J D
Gepirone, a selective serotonin (5HT1A) partial agonist in the treatment of major depression.
Progress in neuro-psychopharmacology & biological psychiatry 1992;16(3):271-80.
1992: Rickels K; Amsterdam J; Clary C; Fox I; Schweizer E; Weise C
The efficacy and safety of paroxetine compared with placebo in outpatients with major depression.
The Journal of clinical psychiatry 1992;53 Suppl():30-2.
1992: Amsterdam J D; Mozley P D
Temporal lobe asymmetry with iofetamine (IMP) SPECT imaging in patients with major depression.
Journal of affective disorders 1992;24(1):43-53.
1991: Amsterdam J D; Maislin G
Effect of erythromycin on tricyclic antidepressant metabolism.
Journal of clinical psychopharmacology 1991;11(3):203-6.
1991: Rickels K; Amsterdam J D; Clary C; Puzzuoli G; Schweizer E
Buspirone in major depression: a controlled study.
The Journal of clinical psychiatry 1991;52(1):34-8.
1990: Amsterdam J D; Maislin G
Comparison of growth hormone response after clonidine and insulin hypoglycemia in affective illness.
Biological psychiatry 1990;28(4):308-14.
1990: Amsterdam J D; Maislin G; Rybakowski J
A possible antiviral action of lithium carbonate in herpes simplex virus infections.
Biological psychiatry 1990;27(4):447-53.
1990: Schweizer E; Rickels K; Amsterdam J D; Fox I; Puzzuoli G; Weise C
What constitutes an adequate antidepressant trial for fluoxetine?
The Journal of clinical psychiatry 1990;51(1):8-11.
1990: Rickels K; Amsterdam J; Clary C; Hassman J; London J; Puzzuoli G; Schweizer E
Buspirone in depressed outpatients: a controlled study.
Psychopharmacology bulletin 1990;26(2):163-7.
1990: Amsterdam J D; Maislin G; Potter L; Giuntoli R
Reduced rate of recurrent genital herpes infections with lithium carbonate.
Psychopharmacology bulletin 1990;26(3):343-7.
1989: Amsterdam J D; Maislin G; Skolnick B; Berwish N; Winokur A
Multiple hormone responses to clonidine administration in depressed patients and healthy volunteers.
Biological psychiatry 1989;26(3):265-78.
1989: Amsterdam J D; Dunner D L; Fabre L F; Kiev A; Rush A J; Goodman L I
Double-blind, placebo-controlled, fixed dose trial of minaprine in patients with major depression.
Pharmacopsychiatry 1989;22(4):137-43.
1989: Amsterdam J D; Maislin G; Berwish N; Phillips J; Winokur A
Enhanced adrenocortical sensitivity to submaximal doses of cosyntropin (alpha1-24-corticotropin) in depressed patients.
Archives of general psychiatry 1989;46(6):550-4.
1989: Amsterdam J D; Berwish N J
High dose tranylcypromine therapy for refractory depression.
Pharmacopsychiatry 1989;22(1):21-5.
1989: Amsterdam J D; Maislin G; Gold P; Winokur A
The assessment of abnormalities in hormonal responsiveness at multiple levels of the hypothalamic-pituitary-adrenocortical axis in depressive illness.
Psychoneuroendocrinology 1989;14(1-2):43-62.
1989: Rickels K; Amsterdam J; Clary C; Fox I; Schweizer E; Weise C
A placebo-controlled, double-blind, clinical trial of paroxetine in depressed outpatients.
Acta psychiatrica Scandinavica. Supplementum 1989;350():117-23.
1988: Jorkasky D K; Amsterdam J D; Oler J; Braden G; Alvis R; Geheb M; Cox M
Lithium-induced renal disease: a prospective study.
Clinical nephrology 1988;30(6):293-302.
1988: Amsterdam J D; Maislin G; Winokur A; Berwish N; Kling M; Gold P
The oCRH stimulation test before and after clinical recovery from depression.
Journal of affective disorders 1988;14(3):213-22.
1988: Winokur A; Maislin G; Phillips J L; Amsterdam J D
Insulin resistance after oral glucose tolerance testing in patients with major depression.
The American journal of psychiatry 1988;145(3):325-30.
1988: Amsterdam J D; Rybakowski J; Gottlieb J; Frazer A
Kinetics of erythrocyte lithium-sodium countertransport in patients with affective illness before and during lithium therapy.
Journal of affective disorders 1988;14(1):75-81.
1987: Amsterdam J D; Settle R G; Doty R L; Abelman E; Winokur A
Taste and smell perception in depression.
Biological psychiatry 1987;22(12):1481-5.
1987: Rickels K; Chung H R; Csanalosi I B; Hurowitz A M; London J; Wiseman K; Kaplan M; Amsterdam J D
Alprazolam, diazepam, imipramine, and placebo in outpatients with major depression.
Archives of general psychiatry 1987;44(10):862-6.
1987: Amsterdam J D; Maislin G; Winokur A; Kling M; Gold P
Pituitary and adrenocortical responses to the ovine corticotropin releasing hormone in depressed patients and healthy volunteers.
Archives of general psychiatry 1987;44(9):775-81.
1987: Amsterdam J D; Berwish N
Treatment of refractory depression with combination reserpine and tricyclic antidepressant therapy.
Journal of clinical psychopharmacology 1987;7(4):238-42.
1986: Amsterdam J D; Maislin G; Abelman E; Berwish N; Winokur A
Adrenocortical responsiveness to the ACTH stimulation test in depressed patients and healthy volunteers.
Journal of affective disorders 1986;11(3):265-74.
1986: Amsterdam J D; Brunswick D J; Potter L; Rickels K
Possible nonlinear pharmacokinetics of desipramine after once daily dosing.
Pharmacopsychiatry 1986;19(2):84-7.
1985: Amsterdam J D; Brunswick D J; Potter L; Winokur A; Rickels K
Desipramine and 2-hydroxydesipramine plasma levels in endogenous depressed patients. Lack of correlation with therapeutic response.
Archives of general psychiatry 1985;42(4):361-4.
1984: Amsterdam J D; Brunswick D J; Potter L; Kaplan M J
Cimetidine-induced alterations in desipramine plasma concentrations.
Psychopharmacology 1984;83(4):373-5.
1983: Amsterdam J D; Winokur A; Abelman E; Lucki I; Rickels K
Cosyntropin (ACTH alpha 1-24) stimulation test in depressed patients and healthy subjects.
The American journal of psychiatry 1983;140(7):907-9.
1983: Brunswick D J; Amsterdam J D; Potter L; Caroff S; Rickels K
Relationship between tricyclic antidepressant plasma levels and clinical response in patients treated with desipramine or doxepin.
Acta psychiatrica Scandinavica 1983;67(6):371-7.
1983: Winokur A; Amsterdam J D; Oler J; Mendels J; Snyder P J; Caroff S N; Brunswick D J
Multiple hormonal responses to protirelin (TRH) in depressed patients.
Archives of general psychiatry 1983;40(5):525-31.
1982: Amsterdam J D; Caroff S; Potter L; Brunswick D; Conn J W; Rickels K
Double-blind comparison of doxepin and desipramine in patients with primary affective disorder.
Acta psychiatrica Scandinavica 1982;65(4):292-300.
1980: Amsterdam J D; Brunswick D J; Mendels J
Reliability of commercially available tricyclic antidepressant levels.
The Journal of clinical psychiatry 1980;41(6):206-7.

Sign-in to see more